In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

As Amanda Phommachanh, a 45-year-old realtor in Manassas, Virginia, describes it, she was on track with Wegovy to meet her ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The radio queen went for a dip at Sydney 's Clovelly beach where she did laps in the tide pool. The 49-year-old showed off ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Gypsy Rose Blanchard hit back at rumors that Child Protective Services was called to check on her baby Aurora Urker, as well ...

Kelly Ripa ’s decision to stop drinking came with one surprise. While asking guest cohost Andy Cohen how his Dry January is going during the latest episode of Live With Kelly and Mark, the 54-year-old ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...